Zantac, a popular heartburn drug sold in the U.S., ended up in the center of a global controversy due to its carcinogen contents.
Read MoreZantac, a popular heartburn drug sold in the U.S., ended up in the center of a global controversy due to its carcinogen contents.
Read More